NACDS offers mini-internship for high school students
nacds promotes pharmacy to his students
Focus of Medicare legislation shifts to oral cancer drug coverage
Medicare bill considers paying for oral cancer drugs
Managed care groups upset over bill to regulate PBMs
Georgia bill regulates PBMs
New treatment guidelines developed for bipolar disorder
APA releases new guidelines to treat bipolar disorder.
New system gives M.D.s information on drug prices
Handheld devices let physicians compare drug prices when they are prescribing
Watch out! Secondhand chemo alert due from NIOSH
NIOSH to publish safety alert related to cytotoxic drugs
Nursing homes, and R.Ph.s, come under new scrutiny
Feds post quality of nursing homes on Web for consumers to comparison shop
THE POWER OF THE PHARMACIST
Pharmacists feel they're gaining authority in some areas and lagging in others
Consumer coalition denounces user fee drug law renewal
PDUFA law renewal draws consumer protest
Arthritis pain guidelines raising some eyebrows
American Pain Society recommends using OxyContin to treat patients with arthritis.
How community pharmacy, managed care can collaborate
Executives from Merck-Medco and Rite Aid speak at AMCP meeting on how to build constructive relationship with each other
Costco Pharmacy: Drug Topics' 2002 chain of the year
drug topics selects costco as pharmacy chain of the year 2002
Reactions mixed to law that lets psychologists prescribe
New Mexico law will allow psychologists to prescribe
Strong trial results prompt update of breast cancer guidelines
New guidelines treat breast cancer.
NACDS' PharmacyCareOneCard receives mixed reaction
NACDS proposes a one-card program but pharmacists have mixed reactions
Survey says: DTC advertising, R&D driving up drug costs
pharmacy benefits trends in US
A new drug for treating relapsing MS gains approval
On March 8, 2002, the FDA announced the approval of interferon beta-1a (Rebif, Serono) for the treatment of relapsing forms of MS. The FDA based its approval on the results of two trials.
Community pharmacy gives thumbs down to Bush Rx card
Community pharmacy rejected the Bush administration's new plan for Medicare Rx discount cards as a rehash of the first proposal unveiled in July, 2001.
Controlled-release abbreviations: Out of control?
An alphabet soup of suffixes has arisen for controlled-release drugs, increasing the potential for drug errors
Pharmacy titles expanding: Do you know what they all mean?
There's an alphabet soup of titles for the pharmacy profession now
VA may limit pharmacists' scope of practice
VA pharmacists may have to give up their prescriptive authority unless their state allows the practice
Third-party contracts: Understanding the deal
Walter Fitzgerald speaks on Third Party Contracting: Understanding the Deal at NCPA conference in Vegas 2002
Chains take to the airwaves in quest for consumers
walgreens and cvs launch new advertising campaigns in 2002
Little state makes big R.Ph. care moves
The Delaware Pharmacist Society has partnered on several projects that pay pharmacists for their services.
JCAHO: Don't fret over CPOE standard
ASHP is alarmed by JCAHO's proposed standard that eliminates the prospective check by an R.Ph. when an Rx is generated by a computerized physician order entry systems.
READY, SET, SURVEY!
JCAHO standards for small, rural hospitals
Merck-Medco to become stand-alone PBM
Merck & Co. announed plans to spin off its Merck-Medco pharmacy benefit manager subsidiary as a separte company.
There's no quick fix for community R.Ph. shortage
An NACDS study projects modest increases in the number of community pharmacists through 2006.
New services help community pharmacies price their drugs competitively
New services help pharmacies negotiate the fine art of drug pricing
